Results
Rekvina Laboratories FY26 Net Loss ₹25.47 Lakh
Rekvina Laboratories reported a standalone net loss of ₹25.47 lakh for FY26, with a Q4 FY26 net loss of ₹6.05 lakh.
The Board approved a 100% acquisition of Radiant Parenterals for ₹4.62 crore via iss
